The major players in the cell signaling market include Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Bio-Techne Corporation (U.S.), and Abcam plc (U.K.)
The cell signaling market is expected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8%. Factors such as increasing incidence of various chronic diseases; rising funding for cell-based research activities; introduction of innovative and advanced instruments; and growing biotech and biopharmaceutical industries are driving the global cell signaling market.
The cell signaling market is categorized based on type, product, technology, pathway, application, and region. The type segment includes endocrine, paracrine, autocrine, juxtacrine, and other types (neuronal and intracrine signaling).The endocrine segment is estimated to account the largest share of the cell signaling market in 2017.
By product, the cell signaling market is categorized into consumables (antibodies, reagents, assay kits and other consumables) and instruments. In 2017, the consumables segment is estimated to account the largest share of the market.
The technology segment of the cell signaling market includes microscopy, western blotting, immunities to chemistry (IHC), flow cytometry, enzyme-linked immunosorbent assay (ELISA), mass spectrometry, and other technologies (immunofluorescence and immunoprecipitation).The microscopy segment is estimated to account for the largest share of the cell signaling market in 2017.
On the basis of the pathway, the cell signaling market is categorized into Akt, AMP-activated protein kinase (AMPK), ErbB/HER, Hedgehog (Hh), Janus kinase and signal transducer and activator of transcription(JAK/STAT), NF-κB, Notch, and other signaling pathways. In 2017, the Akt segment is estimated to account the largest share of the cell signaling market.
Browse complete Cell Signaling Market by type 2017-2022 by new Service spreads across 212 pages profiling 10 companies and supported with 157 tables and 76 figures available at www.reportsnreports.com/reports/99…-st-to-2022.html
Global Cell Signaling Market, By Signaling Type
Other Signaling Types
Global Cell Signaling Market, By Product
Fundamental from Table of Content
13 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Merck KGaA
13.2 Thermo Fisher Scientific Inc.
13.3 Becton, Dickinson and Company
13.4 Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
13.5 Bio-Rad Laboratories, Inc.
13.6 Perkinelmer, Inc
13.7 Qiagen N.V.
13.8 Cell Signaling Technology, Inc.
13.9 Promega Corporation
13.10 Bio-Techne Corporation
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.